"Pancreatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Descriptor ID |
D010190
|
| MeSH Number(s) |
C04.588.274.761 C04.588.322.475 C06.301.761 C06.689.667 C19.344.421
|
| Concept/Terms |
Pancreatic Neoplasms- Pancreatic Neoplasms
- Neoplasm, Pancreatic
- Pancreatic Neoplasm
- Pancreas Neoplasms
- Neoplasm, Pancreas
- Neoplasms, Pancreas
- Pancreas Neoplasm
- Neoplasms, Pancreatic
Cancer of Pancreas- Cancer of Pancreas
- Pancreas Cancers
- Pancreas Cancer
- Cancer, Pancreas
- Cancers, Pancreas
- Pancreatic Cancer
- Cancer, Pancreatic
- Cancers, Pancreatic
- Pancreatic Cancers
- Cancer of the Pancreas
|
Below are MeSH descriptors whose meaning is more general than "Pancreatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Pancreatic Neoplasms".
This graph shows the total number of publications written about "Pancreatic Neoplasms" by people in this website by year, and whether "Pancreatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 2 | 1 | 3 |
| 1998 | 1 | 1 | 2 |
| 1999 | 3 | 1 | 4 |
| 2000 | 2 | 1 | 3 |
| 2001 | 6 | 0 | 6 |
| 2002 | 5 | 7 | 12 |
| 2003 | 1 | 1 | 2 |
| 2004 | 5 | 1 | 6 |
| 2005 | 21 | 3 | 24 |
| 2006 | 10 | 3 | 13 |
| 2007 | 17 | 1 | 18 |
| 2008 | 19 | 3 | 22 |
| 2009 | 16 | 3 | 19 |
| 2010 | 17 | 2 | 19 |
| 2011 | 20 | 5 | 25 |
| 2012 | 11 | 2 | 13 |
| 2013 | 20 | 4 | 24 |
| 2014 | 21 | 1 | 22 |
| 2015 | 18 | 2 | 20 |
| 2016 | 28 | 3 | 31 |
| 2017 | 21 | 4 | 25 |
| 2018 | 19 | 1 | 20 |
| 2019 | 31 | 3 | 34 |
| 2020 | 24 | 3 | 27 |
| 2021 | 5 | 1 | 6 |
| 2022 | 21 | 0 | 21 |
| 2023 | 15 | 0 | 15 |
| 2024 | 21 | 1 | 22 |
| 2025 | 13 | 1 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pancreatic Neoplasms" by people in Profiles.
-
Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer. Nat Commun. 2025 Dec 10; 16(1):11246.
-
SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence. Nat Cancer. 2025 Nov; 6(11):1839-1856.
-
Comparative Risk of Adverse Pancreatic Events With GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP4 Inhibitors, and Sulfonylureas Among Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk. Endocr Pract. 2026 Jan; 32(1):23-30.
-
Stereotactic Body Radiation Therapy Facilitating Debulking Surgery in Metastatic VIPoma with Severe Diarrhea and Hypovolemic Shock. Am J Case Rep. 2025 Sep 06; 26:e949041.
-
Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence. Oncotarget. 2025 Jun 10; 16:427-442.
-
Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy. Theranostics. 2025; 15(13):6444-6453.
-
The Landmark Series: Surgical Management of Functioning and Non-Functioning Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2025 Jul; 32(7):4720-4728.
-
Targeting PIKfyve-driven lipid metabolism in pancreatic cancer. Nature. 2025 Jun; 642(8068):776-784.
-
Afatinib in patients with solid tumors with neuregulin 1 (NRG1) fusions: a case series from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. ESMO Open. 2025 May; 10(5):104545.
-
Neoantigen peptide-pulsed dendritic cell vaccine therapy after surgical treatment of pancreatic cancer: a retrospective study. Front Immunol. 2025; 16:1571182.